Treace Medical Concepts, Inc.

NASDAQ:TMCI

5.48 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -49.527-42.815-20.552-3.668-4.265
Depreciation & Amortization 5.3522.1330.6851.210.793
Deferred Income Tax 15.98200.4192.1430.145
Stock Based Compensation 17.3528.1113.4090.9190.815
Change In Working Capital -9.743-5.809-1.33-5.319-5.308
Accounts Receivables -9.301-11.039-4.226-4.291-6.022
Inventory -9.848-8.769-3.088-3.402-2.813
Accounts Payables 3.1674.6121.7911.334-0.236
Other Working Capital 6.2399.3874.1931.043.763
Other Non Cash Items -13.9917.7320.1760.2210.147
Operating Cash Flow -34.575-30.648-17.193-4.494-7.673
Investing Activities:
Investments In Property Plant And Equipment -11.458-14.838-2.705-1.069-1.211
Acquisitions Net -2061.68000
Purchases Of Investments -169.865-63.409000
Sales Maturities Of Investments 120.0241.729000
Other Investing Activites -49.841-61.68000
Investing Cash Flow -81.299-76.518-2.705-1.069-1.211
Financing Activities:
Debt Repayment 0-33.893-1.788-20-19.671
Common Stock Issued 109.3962.187109.440.3640.068
Common Stock Repurchased -0.0130000
Dividends Paid 00000
Other Financing Activities -0.01352.512107.65231.13939.342
Financing Cash Flow 109.38320.806107.65211.50319.739
Other Information:
Effect Of Forex Changes On Cash 00000
Net Change In Cash -6.491-86.3687.7545.9410.855
Cash At End Of Period 12.98219.473105.83318.07912.139